175 related articles for article (PubMed ID: 31958449)
1. A high-throughput chemotaxis detection method for CCR4
Magnotti EL; Chan LL; Zhu Q; Marasco WA
J Immunol Methods; 2020 Apr; 479():112747. PubMed ID: 31958449
[TBL] [Abstract][Full Text] [Related]
2. Synergistic effect of regulatory T cells and proinflammatory cytokines in angiogenesis in the endometriotic milieu.
Wang XQ; Zhou WJ; Luo XZ; Tao Y; Li DJ
Hum Reprod; 2017 Jun; 32(6):1304-1317. PubMed ID: 28383711
[TBL] [Abstract][Full Text] [Related]
3. CCL17 and CCL22 induce CCR4 receptor expression and promote cytokine-induced killer cells migration.
Dong Y; Gao S; Zhang X; Kou J; Liu J; Ye T; Shen H
Anticancer Drugs; 2022 Feb; 33(2):149-157. PubMed ID: 34657098
[TBL] [Abstract][Full Text] [Related]
4. Expression of chemokine receptor CCR4 and its ligands (CCL17 and CCL22) in murine contact hypersensitivity.
Kusumoto M; Xu B; Shi M; Matsuyama T; Aoyama K; Takeuchi T
J Interferon Cytokine Res; 2007 Nov; 27(11):901-10. PubMed ID: 18052724
[TBL] [Abstract][Full Text] [Related]
5. Distinct conformations of the chemokine receptor CCR4 with implications for its targeting in allergy.
Viney JM; Andrew DP; Phillips RM; Meiser A; Patel P; Lennartz-Walker M; Cousins DJ; Barton NP; Hall DA; Pease JE
J Immunol; 2014 Apr; 192(7):3419-27. PubMed ID: 24563252
[TBL] [Abstract][Full Text] [Related]
6. CCL17 and CCL22 chemokines within tumor microenvironment are related to accumulation of Foxp3+ regulatory T cells in gastric cancer.
Mizukami Y; Kono K; Kawaguchi Y; Akaike H; Kamimura K; Sugai H; Fujii H
Int J Cancer; 2008 May; 122(10):2286-93. PubMed ID: 18224687
[TBL] [Abstract][Full Text] [Related]
7. Engagement of two distinct binding domains on CCL17 is required for signaling through CCR4 and establishment of localized inflammatory conditions in the lung.
Santulli-Marotto S; Boakye K; Lacy E; Wu SJ; Luongo J; Kavalkovich K; Coelho A; Hogaboam CM; Ryan M
PLoS One; 2013; 8(12):e81465. PubMed ID: 24339934
[TBL] [Abstract][Full Text] [Related]
8. CCL17 and CCL22 chemokines within tumor microenvironment are related to infiltration of regulatory T cells in esophageal squamous cell carcinoma.
Maruyama T; Kono K; Izawa S; Mizukami Y; Kawaguchi Y; Mimura K; Watanabe M; Fujii H
Dis Esophagus; 2010 Jul; 23(5):422-9. PubMed ID: 20002703
[TBL] [Abstract][Full Text] [Related]
9. In silico identified CCR4 antagonists target regulatory T cells and exert adjuvant activity in vaccination.
Bayry J; Tchilian EZ; Davies MN; Forbes EK; Draper SJ; Kaveri SV; Hill AV; Kazatchkine MD; Beverley PC; Flower DR; Tough DF
Proc Natl Acad Sci U S A; 2008 Jul; 105(29):10221-6. PubMed ID: 18621704
[TBL] [Abstract][Full Text] [Related]
10. Cross talk between follicular Th cells and tumor cells in human follicular lymphoma promotes immune evasion in the tumor microenvironment.
Rawal S; Chu F; Zhang M; Park HJ; Nattamai D; Kannan S; Sharma R; Delgado D; Chou T; Lin HY; Baladandayuthapani V; Luong A; Vega F; Fowler N; Dong C; Davis RE; Neelapu SS
J Immunol; 2013 Jun; 190(12):6681-93. PubMed ID: 23686488
[TBL] [Abstract][Full Text] [Related]
11. Differential expression of Th2 chemokine receptors on T cells from atopic and nonatopic asthmatics in response to Der p 1-pulsed dendritic cells.
Maneechotesuwan K; Wongkajornsilp A; Huabprasert S; Kasetsinsombat K; Suthumansami T
J Med Assoc Thai; 2010 Jan; 93 Suppl 1():S62-70. PubMed ID: 20364559
[TBL] [Abstract][Full Text] [Related]
12. Surrogate antibodies that specifically bind and neutralize CCL17 but not CCL22.
Santulli-Marotto S; Fisher J; Petley T; Boakye K; Panavas T; Luongo J; Kavalkovich K; Rycyzyn M; Wu B; Gutshall L; Coelho A; Hogaboam CM; Ryan M
Monoclon Antib Immunodiagn Immunother; 2013 Jun; 32(3):162-71. PubMed ID: 23750473
[TBL] [Abstract][Full Text] [Related]
13. Evidence that phospholipase-C-dependent, calcium-independent mechanisms are required for directional migration of T-lymphocytes in response to the CCR4 ligands CCL17 and CCL22.
Cronshaw DG; Kouroumalis A; Parry R; Webb A; Brown Z; Ward SG
J Leukoc Biol; 2006 Jun; 79(6):1369-80. PubMed ID: 16614259
[TBL] [Abstract][Full Text] [Related]
14. Breast cancer lung metastasis requires expression of chemokine receptor CCR4 and regulatory T cells.
Olkhanud PB; Baatar D; Bodogai M; Hakim F; Gress R; Anderson RL; Deng J; Xu M; Briest S; Biragyn A
Cancer Res; 2009 Jul; 69(14):5996-6004. PubMed ID: 19567680
[TBL] [Abstract][Full Text] [Related]
15. Altered frequency and migration capacity of CD4+CD25+ regulatory T cells in systemic lupus erythematosus.
Lee HY; Hong YK; Yun HJ; Kim YM; Kim JR; Yoo WH
Rheumatology (Oxford); 2008 Jun; 47(6):789-94. PubMed ID: 18388146
[TBL] [Abstract][Full Text] [Related]
16. CCL17 acts as an antitumor chemokine in micromilieu-driven immune skewing.
Li Y; Cao H; Jiang Z; Yan K; Shi J; Wang S; Wang F; Wang W; Li X; Sun N; Liu L; Chen L; Chen Y; Guo R; Song Y
Int Immunopharmacol; 2023 May; 118():110078. PubMed ID: 37001380
[TBL] [Abstract][Full Text] [Related]
17. CCL22 Signaling in the Tumor Environment.
Röhrle N; Knott MML; Anz D
Adv Exp Med Biol; 2020; 1231():79-96. PubMed ID: 32060848
[TBL] [Abstract][Full Text] [Related]
18. Internalization of the chemokine receptor CCR4 can be evoked by orthosteric and allosteric receptor antagonists.
Ajram L; Begg M; Slack R; Cryan J; Hall D; Hodgson S; Ford A; Barnes A; Swieboda D; Mousnier A; Solari R
Eur J Pharmacol; 2014 Apr; 729(100):75-85. PubMed ID: 24534492
[TBL] [Abstract][Full Text] [Related]
19. Tumor-associated macrophages promote prostate cancer migration through activation of the CCL22-CCR4 axis.
Maolake A; Izumi K; Shigehara K; Natsagdorj A; Iwamoto H; Kadomoto S; Takezawa Y; Machioka K; Narimoto K; Namiki M; Lin WJ; Wufuer G; Mizokami A
Oncotarget; 2017 Feb; 8(6):9739-9751. PubMed ID: 28039457
[TBL] [Abstract][Full Text] [Related]
20. A strategy to discover decoy chemokine ligands with an anti-inflammatory activity.
Abboud D; Daubeuf F; Do QT; Utard V; Villa P; Haiech J; Bonnet D; Hibert M; Bernard P; Galzi JL; Frossard N
Sci Rep; 2015 Oct; 5():14746. PubMed ID: 26442456
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
